Oman Rial vs United Arab Emirates Dirham News - OMRAED

Biopharma on a Tear After Certificate of Grant from Japanese Patent Office

This biopharma is developing novel cancer treatments for patients suffering from recurring and metastatic cancer. Shares were trading up after the...

Quarterly Report (10-q)

0001517681 false 2023 Q3 --06-30 http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#Re...

Current Report Filing (8-k)

0001517681 false 0001517681 2023-05-15 2023-05-15 iso4217:USD xbrli:shares...

Current Report Filing (8-k)

0001517681 false --06-30 0001517681 2023-05-05 2023-05-05 iso4217:USD...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-238240 PROSPECTUS Propanc Biopharma...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:March 27, 2023...

Post-effective Amendment to Registration Statement (pos Am)

0001517681 true POS AM Post-Effective Amendment Number 2

Current Report Filing (8-k)

0001517681 false 0001517681 2023-02-14 2023-02-14 iso4217:USD xbrli:shares...

Quarterly Report (10-q)

0001517681 false Q2 --06-30 2023

Quarterly Report (10-q)

0001517681 false Q1 --06-30 2023

Proxy Statement - Other Information (preliminary) (pre 14c)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C (Rul...

Sometimes All It Takes Is A Mention

In the biotech space, sometimes all it takes for a stock to move is a simple indication that things are going well during a specific trial or if...

Proxy Statement - Other Information (preliminary) (pre 14c)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C (Rul...

Current Report Filing (8-k)

0001517681 false 0001517681 2022-05-12 2022-05-12 iso4217:USD xbrli:shares...

Quarterly Report (10-q)

0001517681 false Q3 --06-30

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Oman Rial vs United Arab Emirates Dirham (OMRAED)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

OMRAED News

Biopharma on a Tear After Certificate of Grant from Japanese Patent Office

Quarterly Report (10-q)

Current Report Filing (8-k)

Current Report Filing (8-k)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Notice of Effectiveness (effect)

Post-effective Amendment to Registration Statement (pos Am)

Current Report Filing (8-k)

Quarterly Report (10-q)

Quarterly Report (10-q)

Proxy Statement - Other Information (preliminary) (pre 14c)

Sometimes All It Takes Is A Mention

Proxy Statement - Other Information (preliminary) (pre 14c)

Current Report Filing (8-k)

Quarterly Report (10-q)

OMRAED Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Oman Rial vs United Arab Emirates Dirham (OMRAED) News

Oman Rial vs United Arab Emirates Dirham (OMRAED)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

OMRAED News

Biopharma on a Tear After Certificate of Grant from Japanese Patent Office

Quarterly Report (10-q)

Current Report Filing (8-k)

Current Report Filing (8-k)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Notice of Effectiveness (effect)

Post-effective Amendment to Registration Statement (pos Am)

Current Report Filing (8-k)

Quarterly Report (10-q)

Quarterly Report (10-q)

Proxy Statement - Other Information (preliminary) (pre 14c)

Sometimes All It Takes Is A Mention

Proxy Statement - Other Information (preliminary) (pre 14c)

Current Report Filing (8-k)

Quarterly Report (10-q)

OMRAED Discussion

Your Recent History